Stay updated on Elafibranor in NASH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.

Latest updates to the Elafibranor in NASH: Efficacy & Safety Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check16 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and inclusion criteria for a clinical trial on Elafibranor for NASH, while adding a new revision number and a reference to a specific EudraCT number.SummaryDifference12%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated to version 2.14.3, replacing the previous version 2.14.2. Additionally, a notice regarding heavy traffic affecting some NLM-NCBI services and products has been removed.SummaryDifference0.6%
- Check88 days agoChange DetectedThe web page has been updated to reflect a new version, v2.14.2, and includes a notice about heavy traffic affecting the performance and availability of some services and products.SummaryDifference0.6%
- Check112 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
Stay in the know with updates to Elafibranor in NASH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.